Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)

SHA:600513 Revenue

Jiangsu Lianhuan Pharmaceutical had revenue of 760.19M CNY in the quarter ending June 30, 2026, with 15.59% growth. This brings the company's total for the last twelve months to 3.00B, up 29.23% year-over-year. In the year 2025, Jiangsu Lianhuan Pharmaceutical had annual revenue of 2.71B with 25.52% growth. That makes Jiangsu Lianhuan Pharmaceutical the 11,837th largest company in the world by revenue and 2,004th in China.

• Revenue (ttm): 3.00B
• Revenue Growth: +29.23%
• P/S Ratio: 1.30
• Revenue / Employee: 1.41M
• Employees: 2,131
• Market Cap: 3.91B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine Circulation 1.60B 59.4%
• Pharmaceutical Manufacturing 1.10B 40.6%

By Geography

Chart

• China 2.65B 97.8%
• Overseas 59.96M 2.2%

Fiscal year ended Dec 31, 2025 See the full SHA:600513 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.71B	551.40M	25.52%
Dec 31, 2024	2.16B	-13.64M	-0.63%
Dec 31, 2023	2.17B	218.94M	11.20%
Dec 31, 2022	1.96B	309.34M	18.80%
Dec 31, 2021	1.65B	259.78M	18.74%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error